©The Author(s) 2025.
World J Gastrointest Oncol. Nov 15, 2025; 17(11): 110735
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.110735
Published online Nov 15, 2025. doi: 10.4251/wjgo.v17.i11.110735
Figure 2 Proposed algorithm for management of recurrent hepatocellular carcinoma.
RHCC: Recurrent hepatocellular carcinoma; CTP: Child-Turcotte-Pugh; MELD: Model for end-stage liver disease; BCLC: Barcelona Clinic Liver Cancer; Tx: Transplant; BSC: Best supportive care; PV: Portal vein; TACE: Transcatheter arterial chemoembolization.
- Citation: Elsayed MOK. Treatment of recurrent hepatocellular carcinoma: The current standards and future perspectives. World J Gastrointest Oncol 2025; 17(11): 110735
- URL: https://www.wjgnet.com/1948-5204/full/v17/i11/110735.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i11.110735